Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Cell cycle progression: new therapeutic target for vascular proliferative disease.

Braun-Dullaeus RC, Mann MJ, Dzau VJ.

Circulation. 1998 Jul 7;98(1):82-9. Review.

2.

Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin.

Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, Dzau VJ.

Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1152-8.

3.

Esculetin inhibits Ras-mediated cell proliferation and attenuates vascular restenosis following angioplasty in rats.

Pan SL, Huang YW, Guh JH, Chang YL, Peng CY, Teng CM.

Biochem Pharmacol. 2003 Jun 1;65(11):1897-905.

PMID:
12781342
4.
5.

Regulation of smooth muscle cells in development and vascular disease: current therapeutic strategies.

Cai X.

Expert Rev Cardiovasc Ther. 2006 Nov;4(6):789-800. Review.

PMID:
17173496
6.

Posttranslational nitrotyrosination of alpha-tubulin induces cell cycle arrest and inhibits proliferation of vascular smooth muscle cells.

Phung AD, Soucek K, Kubala L, Harper RW, Chloë Bulinski J, Eiserich JP.

Eur J Cell Biol. 2006 Dec;85(12):1241-52.

PMID:
17118269
7.

Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.

Fiaschi-Taesch N, Sicari BM, Ubriani K, Bigatel T, Takane KK, Cozar-Castellano I, Bisello A, Law B, Stewart AF.

Circ Res. 2006 Oct 27;99(9):933-42.

8.

Break the cycle: the role of cell-cycle modulation in the prevention of vasculoproliferative diseases.

Ferguson JE 3rd, Patterson C.

Cell Cycle. 2003 May-Jun;2(3):211-9. Review.

PMID:
12734427
10.

Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.

Peng CY, Pan SL, Huang YW, Guh JH, Chang YL, Teng CM.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Dec;378(6):579-88. doi: 10.1007/s00210-008-0328-1.

PMID:
18663431
11.

RNA interference targeting ORC1 gene suppresses the proliferation of vascular smooth muscle cells in rats.

Shu MQ, Qin YL, Jiang MH.

Exp Mol Pathol. 2008 Jun;84(3):206-12. doi: 10.1016/j.yexmp.2008.03.001.

PMID:
18499104
12.

Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases.

Rivard A, Andrés V.

Histol Histopathol. 2000 Apr;15(2):557-71. Review.

PMID:
10809377
13.

T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells.

Ivanov D, Philippova M, Allenspach R, Erne P, Resink T.

Cardiovasc Res. 2004 Oct 1;64(1):132-43.

PMID:
15364621
14.

Cell cycle-dependent regulation of smooth muscle cell activation.

Braun-Dullaeus RC, Mann MJ, Sedding DG, Sherwood SW, von der Leyen HE, Dzau VJ.

Arterioscler Thromb Vasc Biol. 2004 May;24(5):845-50.

15.

Targeting the cell cycle machinery for the treatment of cardiovascular disease.

Bicknell KA, Surry EL, Brooks G.

J Pharm Pharmacol. 2003 May;55(5):571-91. Review.

PMID:
12831500
16.
18.

Control of smooth muscle cell proliferation in vascular disease.

Hedin U, Roy J, Tran PK.

Curr Opin Lipidol. 2004 Oct;15(5):559-65. Review.

PMID:
15361792
19.
20.

[Gene therapy in heart diseases].

Tanner FC, Largiadèr T, Yang Z, Lüscher TF.

Schweiz Med Wochenschr. 1999 Nov 20;129(46):1784-91. Review. German.

PMID:
10603653

Supplemental Content

Support Center